{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:13:22Z","timestamp":1793445202955,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC43\/24"],"award-info":[{"award-number":["RC43\/24"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-025-06660-1","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T05:25:40Z","timestamp":1764393940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Off-label prescribing in Italian pediatric practice: insights from a nationwide survey"],"prefix":"10.1007","volume":"184","author":[{"given":"Anna","family":"Arbo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Flamigni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Zamagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Migliore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"6660_CR1","first-page":"776","volume":"111","author":"HC Allen","year":"2018","unstructured":"Allen HC, Garbe MC, Lees J et al (2018) Off-label medication use in children, more common than we think: a systematic review of the literature. J Okla State Med Assoc 111:776\u2013783","journal-title":"J Okla State Med Assoc"},{"key":"6660_CR2","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/clpt.2012.26","volume":"91","author":"E Kimland","year":"2012","unstructured":"Kimland E, Odlind V (2012) Off-label drug use in pediatric patients. Clin Pharmacol Ther 91:796\u2013801","journal-title":"Clin Pharmacol Ther"},{"key":"6660_CR3","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/archdischild-2013-305212","volume":"99","author":"SN De Wildt","year":"2014","unstructured":"De Wildt SN, Tibboel D, Leeder JS (2014) Drug metabolism for the paediatrician. Arch Dis Child 99:1137\u20131142","journal-title":"Arch Dis Child"},{"key":"6660_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bcp.12267","volume":"79","author":"HK Batchelor","year":"2015","unstructured":"Batchelor HK, Marriott JF (2015) Paediatric pharmacokinetics: key considerations. Br J Clin Pharmacol 79:395\u2013404","journal-title":"Br J Clin Pharmacol"},{"key":"6660_CR5","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s00044-024-03360-7","volume":"33","author":"M Vander Schaaf","year":"2024","unstructured":"Vander Schaaf M, Luth K, Townsend DM et al (2024) CYP3A4 drug metabolism considerations in pediatric pharmacotherapy. Med Chem Res 33:2221\u20132235","journal-title":"Med Chem Res"},{"key":"6660_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105720","volume":"96","author":"DU Kapoor","year":"2024","unstructured":"Kapoor DU, Garg R, Gaur M et al (2024) Pediatric drug delivery challenges: enhancing compliance through age-appropriate formulations and safety measures. J Drug Deliv Sci Technol 96:105720","journal-title":"J Drug Deliv Sci Technol"},{"key":"6660_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15122652","volume":"15","author":"V Petkova","year":"2023","unstructured":"Petkova V, Georgieva D, Dimitrov M et al (2023) Off-label prescribing in pediatric population\u2014literature review for 2012\u20132022. Pharmaceutics 15:2652","journal-title":"Pharmaceutics"},{"key":"6660_CR8","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.22271\/tpi.2019.v8.i4s.25510","volume":"8","author":"DrF Iram","year":"2019","unstructured":"Iram DrF, Yadav P (2019) Pediatric pharmacotherapy: medication management in children. Pharm Innovati 8:1272\u20131275","journal-title":"Pharm Innovati"},{"key":"6660_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpeds.2024.100224","volume":"9","author":"C Magendie","year":"2024","unstructured":"Magendie C, Huss G, Reali L et al (2024) Shortage of essential pediatric medications puts children\u2019s health at risk. Results from a European Confederation of Primary Care Paediatricians (ECPCP) survey 2023. Glob Pediatr 9:100224","journal-title":"Glob Pediatr"},{"key":"6660_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1136\/ejhpharm-2019-001977","volume":"28","author":"A Van Der Vossen","year":"2021","unstructured":"Van Der Vossen A, Bulja\u00e7 S, Ak\u00e7ay K et al (2021) Availability of age-appropriate paediatric formulations in the Netherlands: the need in daily clinical practice remains. Eur J Hosp Pharm 28:306\u2013312","journal-title":"Eur J Hosp Pharm"},{"key":"6660_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1200848","author":"E Barbieri","year":"2023","unstructured":"Barbieri E, Minotti C, Cavagnis S et al (2023) Paediatric medicine issues and gaps from healthcare workers point of view: survey results and a narrative review from the global accelerator for paediatric formulations project. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2023.1200848","journal-title":"Front Pharmacol"},{"key":"6660_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-018-0584-8","author":"L De Zen","year":"2018","unstructured":"De Zen L, Marchetti F, Barbi E et al (2018) Off-label drugs use in pediatric palliative care. Ital J Pediatr. https:\/\/doi.org\/10.1186\/s13052-018-0584-8","journal-title":"Ital J Pediatr"},{"key":"6660_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11100518","volume":"11","author":"SE Gerrard","year":"2019","unstructured":"Gerrard SE, Walsh J, Bowers N et al (2019) Innovations in pediatric drug formulations and administration technologies for low resource settings. Pharmaceutics 11:518","journal-title":"Pharmaceutics"},{"issue":"2","key":"6660_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.37532\/ipdr.2023.6(2).31-33","volume":"6","author":"J Smith","year":"2023","unstructured":"Smith J (2023) Pediatric pharmacology understanding medications for children. Interve Pedia Rese 6(2):31\u201333. https:\/\/doi.org\/10.37532\/ipdr.2023.6(2).31-33","journal-title":"Interve Pedia Rese"},{"key":"6660_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.18773\/austprescr.2016.071","volume":"39","author":"K O\u2019Hara","year":"2016","unstructured":"O\u2019Hara K (2016) Paediatric pharmacokinetics and drug doses. Aust Prescr 39:208\u2013210","journal-title":"Aust Prescr"},{"key":"6660_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1456247","volume":"11","author":"S Wang","year":"2024","unstructured":"Wang S, Giannuzzi V (2024) Paediatric formulations\u2014part of the repurposing concept? Front Med 11:1456247","journal-title":"Front Med"},{"key":"6660_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jphs.12286","volume":"10","author":"R Rajan","year":"2019","unstructured":"Rajan R, Peter SM, Kurian VM et al (2019) The practice of off label prescribing and associated adverse drug reactions in pediatric inpatients in a tertiary care hospital in India. J Pharm Health Serv Res 10:29\u201334","journal-title":"J Pharm Health Serv Res"},{"key":"6660_CR18","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.4103\/0976-500X.120960","volume":"4","author":"F Saullo","year":"2013","unstructured":"Saullo F, Saullo E, Caloiero M et al (2013) A questionnaire-based study in Calabria on the knowledge of off-label drugs in pediatrics. J Pharmacol Pharmacother 4:S51\u2013S54","journal-title":"J Pharmacol Pharmacother"},{"key":"6660_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/children12020124","volume":"12","author":"D Mengato","year":"2025","unstructured":"Mengato D, Zanin A, Baratiri F et al (2025) Polypharmacy in pediatric palliative care: exploring discrepancies between physicians and pharmacists. Children 12:124","journal-title":"Children"},{"key":"6660_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101704","volume":"31","author":"S Lee","year":"2023","unstructured":"Lee S, Yang MH, Kim JS et al (2023) Evaluation of off-label medication use and drug safety in a pediatric intensive care unit. Saudi Pharm J 31:101704","journal-title":"Saudi Pharm J"},{"key":"6660_CR21","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jpainsymman.2020.06.014","volume":"60","author":"I Garc\u00eda-L\u00f3pez","year":"2020","unstructured":"Garc\u00eda-L\u00f3pez I, Cuervas-Mons Vendrell M, Mart\u00edn Romero I et al (2020) Off-label and unlicensed drugs in pediatric palliative care: a prospective observational study. J Pain Symptom Manage 60:923\u2013932","journal-title":"J Pain Symptom Manage"},{"key":"6660_CR22","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1177\/0018578720942226","volume":"56","author":"A AlAzmi","year":"2021","unstructured":"AlAzmi A, Alasmari Z, Yousef C et al (2021) Off-label drug use in pediatric out-patient care: a multi-center observational study. Hosp Pharm 56:690\u2013696","journal-title":"Hosp Pharm"},{"key":"6660_CR23","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/2168479013491753","volume":"47","author":"H Wu","year":"2013","unstructured":"Wu H, Wu G (2013) Improving good practice: a survey of unlicensed and off-label drug use in a general hospital in China. Ther Innov Regul Sci 47:397\u2013404","journal-title":"Ther Innov Regul Sci"},{"key":"6660_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/JRS-150654","volume":"27","author":"IC Ellul","year":"2015","unstructured":"Ellul IC, Grech V, Attard-Montalto S (2015) Paediatric off-label and unlicensed prescribing in primary care in Malta: prospective observational drug utilisation study. Int J Risk Saf Med 27:123\u2013134","journal-title":"Int J Risk Saf Med"},{"key":"6660_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13869","author":"B Park","year":"2024","unstructured":"Park B, Lee H, Choi H et al (2024) Age\u2010related off\u2010label drug prescribing in pediatric patients in South Korea and consistency of labeling compared to the United States, Europe, and Japan. Clin Transl Sci. https:\/\/doi.org\/10.1111\/cts.13869","journal-title":"Clin Transl Sci"},{"key":"6660_CR26","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00431-013-2111-7","volume":"172","author":"C Carnovale","year":"2013","unstructured":"Carnovale C, Conti V, Perrone V et al (2013) Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches. Eur J Pediatr 172:1679\u20131685","journal-title":"Eur J Pediatr"},{"key":"6660_CR27","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/cpt.2336","volume":"110","author":"TM Van Der Zanden","year":"2021","unstructured":"Van Der Zanden TM, Mooij MG, Vet NJ et al (2021) Benefit\u2010risk assessment of off-label drug use in children: the Bravo framework. Clin Pharmacol Ther 110:952\u2013965","journal-title":"Clin Pharmacol Ther"},{"key":"6660_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1542\/peds.2014-0764","volume":"135","author":"A Palmaro","year":"2015","unstructured":"Palmaro A, Bissuel R, Renaud N et al (2015) Off-label prescribing in pediatric outpatients. Pediatrics 135:49\u201358","journal-title":"Pediatrics"},{"key":"6660_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.therap.2018.02.002","volume":"73","author":"F Moulis","year":"2018","unstructured":"Moulis F, Durrieu G, Lapeyre-Mestre M (2018) Off-label and unlicensed drug use in children population. Therapies 73:135\u2013149","journal-title":"Therapies"},{"key":"6660_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-024-02698-8","author":"V Bencheva","year":"2024","unstructured":"Bencheva V, Mann N-K, Rombey T et al (2024) Barriers and facilitators to enrollment in pediatric clinical trials: an overview of systematic reviews. Syst Rev. https:\/\/doi.org\/10.1186\/s13643-024-02698-8","journal-title":"Syst Rev"},{"key":"6660_CR31","first-page":"1210","volume":"12","author":"AM Shanshal","year":"2021","unstructured":"Shanshal AM, Hussain SA (2021) Off-label prescribing practice in pediatric settings: pros and cons. Syst Rev Pharm 12:1210\u20131218","journal-title":"Syst Rev Pharm"},{"key":"6660_CR32","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2024.12701","author":"X Yuan","year":"2024","unstructured":"Yuan X, Gao J, Yang L et al (2024) Off\u2011label and unapproved pediatric drug utilization: a meta\u2011analysis. Exp Ther Med. https:\/\/doi.org\/10.3892\/etm.2024.12701","journal-title":"Exp Ther Med"},{"key":"6660_CR33","unstructured":"European Medicines Agency. Evidence of harm from off-label or unlicensed medicines in children. Pre-authorisation evaluation of medicines for human use. Available on https:\/\/www.ema.europa.eu\/en\/documents\/other\/evidence-harm-label-or-unlicensed-medicines-children_en.pdf. Accessed 28 Aug 2025"},{"key":"6660_CR34","doi-asserted-by":"crossref","unstructured":"Degraeuwe E, Lepola P, Turner M et al 31 An update on the challenges of conducting pediatric clinical trials: 15 years of progress since EMA regulation implementation. Available on https:\/\/bmjpaedsopen.bmj.com\/content\/bmjpo\/8\/Suppl_6\/A15.1.full.pdf. Accessed 28 Aug 2025","DOI":"10.1136\/bmjpo-2024-ESDPPP.31"},{"key":"6660_CR35","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1007\/s00431-022-04515-7","volume":"181","author":"M Meng","year":"2022","unstructured":"Meng M, Lv M, Wang L et al (2022) Off-label use of drugs in pediatrics: a scoping review. Eur J Pediatr 181:3259\u20133269","journal-title":"Eur J Pediatr"},{"key":"6660_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.892574","author":"M Meng","year":"2022","unstructured":"Meng M, Zhou Q, Lei W et al (2022) Recommendations on off-label drug use in pediatric guidelines. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.892574","journal-title":"Front Pharmacol"},{"key":"6660_CR37","doi-asserted-by":"crossref","unstructured":"Committee on Drugs, Neville KA, Frattarelli DAC et al (2014) Off-label use of drugs in children. Pediatrics 133:563\u2013567","DOI":"10.1542\/peds.2013-4060"},{"key":"6660_CR38","doi-asserted-by":"publisher","first-page":"238","DOI":"10.5582\/irdr.2021.01104","volume":"10","author":"A Fung","year":"2021","unstructured":"Fung A, Yue X, Wigle PR et al (2021) Off-label medication use in rare pediatric diseases in the United States. Intractable & Rare Diseases Research 10:238\u2013245","journal-title":"Intractable & Rare Diseases Research"},{"key":"6660_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.rare.2024.100018","volume":"2","author":"P Pakter","year":"2024","unstructured":"Pakter P (2024) Rare disease care in Europe \u2013 gaping unmet needs. Rare 2:100018","journal-title":"Rare"},{"key":"6660_CR40","unstructured":"Andreu P, Atay NJ, Piccinini E et al Rare disease burden of care and the economic impact on citizens in Germany, France and Italy. Available on https:\/\/chiesirarediseases.com\/assets\/pdf\/rare-disease-burden-of-care-and-the-economic-impact-on-citizens.pdf. Accessed 28 Aug 2025"},{"key":"6660_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(24)00056-1","volume":"12","author":"TLG Health","year":"2024","unstructured":"Health TLG (2024) The landscape for rare diseases in 2024. Lancet Glob Health 12:e341","journal-title":"Lancet Glob Health"},{"key":"6660_CR42","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00431-019-03556-9","volume":"179","author":"L Schrier","year":"2020","unstructured":"Schrier L, Hadjipanayis A, Stiris T et al (2020) Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology. Eur J Pediatr 179:839\u2013847","journal-title":"Eur J Pediatr"},{"key":"6660_CR43","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s11096-021-01303-5","volume":"44","author":"B Guidi","year":"2022","unstructured":"Guidi B, Parziale A, Nocco L et al (2022) Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions: comparative regulation framework of off label prescriptions in pediatrics: a review. Int J Clin Pharm 44:264\u2013269","journal-title":"Int J Clin Pharm"},{"key":"6660_CR44","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1111\/bcp.15995","volume":"90","author":"M Di Salvo","year":"2024","unstructured":"Di Salvo M, Santi Laurini G, Motola D et al (2024) PAttern of drug use in PEdiatrics: an observational study in Italian hOSpitals (the PAPEOS study). Br J Clin Pharmacol 90:1050\u20131057","journal-title":"Br J Clin Pharmacol"},{"key":"6660_CR45","unstructured":"Gazzetta Ufficiale. Conversione in legge, con modificazioni, del decreto-legge 17 febbraio 1998, n. 23, recante disposizioni urgenti in materia di sperimentazioni cliniche in campo oncologico e altre misure in materia sanitaria. Sect. Articolo 1, Legge di conversione 94\/98 Apr 14, 1998"},{"key":"6660_CR46","unstructured":"Gazzetta Ufficiale. Ripubblicazione del testo della legge 24 dicembre 2007, n. 244, recante: \u00abDisposizioni per la formazione del bilancio annuale e pluriennale dello Stato (legge finanziaria 2008)\u00bb, corredato delle relative note. (Legge pubblicata nel supplemento ordinario n. 285\/L alla Gazzetta Ufficiale - serie generale - n. 300 del 28 dicembre 2007). (GU Serie Generale n.10 del 12\u201301\u20132008 - Suppl. Ordinario n. 8)"},{"key":"6660_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12910-018-0263-8","author":"L De Panfilis","year":"2018","unstructured":"De Panfilis L, Satolli R, Costantini M (2018) Compassionate use programs in Italy: ethical guidelines. BMC Med Ethics. https:\/\/doi.org\/10.1186\/s12910-018-0263-8","journal-title":"BMC Med Ethics"},{"key":"6660_CR48","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.0475","volume":"3","author":"P Aliu","year":"2022","unstructured":"Aliu P, Sarp S, Reichenbach R et al (2022) International country-level trends, factors, and disparities in compassionate use access to unlicensed products for patients with serious medical conditions. JAMA Health Forum 3:e220475","journal-title":"JAMA Health Forum"},{"key":"6660_CR49","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1517\/14740338.5.5.703","volume":"5","author":"L Cuzzolin","year":"2006","unstructured":"Cuzzolin L, Atzei A, Fanos V (2006) Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf 5:703\u2013718","journal-title":"Expert Opin Drug Saf"},{"key":"6660_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/bcp.70168","author":"A Flamigni","year":"2025","unstructured":"Flamigni A, Zamagni G, Paternuosto G et al (2025) Paediatric rare diseases: can large language models assist off-label prescribing? Br J Clin Pharmacol. https:\/\/doi.org\/10.1002\/bcp.70168","journal-title":"Br J Clin Pharmacol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06660-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-025-06660-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-025-06660-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:43:50Z","timestamp":1768459430000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-025-06660-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":50,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6660"],"URL":"https:\/\/doi.org\/10.1007\/s00431-025-06660-1","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is an observational study. The INCiPiT scientific committee has confirmed that no ethical approval is required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"807"}}